PATENT CLAIM ANALYSIS

Application Number: 16037812
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2018-12
Patent Classification: ["544", "400000"]

Abstract:
The invention provides compounds and compositions useful for the modulation of certain enzymes. The compounds and compositions can induce of cell death, particularly cancer cell death. The invention also provides methods for the synthesis and use of the compounds and compositions, including the use of compounds and compositions in therapy for the treatment of cancer and selective induction of apoptosis in cells.

Claim (Index 12):
The method of  claim 11  wherein each R 2  is t-butyl.

Metadata:
- Claim Count in Document: 50.0
- Percentile: 95.0
- Lexical Diversity: 2.0303
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13652164', '14417524', '15013667', '14321514', '13676650']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7388160318697614
- 35 USC 102 Novelty (BERT): 0.5485659148625195
- Combined Prediction Score: 0.7197910201690373
- Mean Citation Score: 319.372486
- Max Citation Score: 403.87213
- Similarity Product: 282.08457308688764

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test